These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3977714)

  • 1. Differentiation between recently resolved optic neuritis and central serous retinopathy. Use of tests of visual function.
    Han DP; Thompson HS; Folk JC
    Arch Ophthalmol; 1985 Mar; 103(3):394-6. PubMed ID: 3977714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual function abnormalities in central serous retinopathy.
    Folk JC; Thompson HS; Han DP; Brown CK
    Arch Ophthalmol; 1984 Sep; 102(9):1299-302. PubMed ID: 6477246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serous retinopathy, the Farnsworth-Munsell 100-Hue Test, and prolactin.
    Coppeto JR
    Arch Ophthalmol; 1985 Mar; 103(3):323, 325. PubMed ID: 3977701
    [No Abstract]   [Full Text] [Related]  

  • 4. Optic neuritis: differential diagnosis.
    Bianchi Marzoli S; Martinelli V
    Neurol Sci; 2001 Nov; 22 Suppl 2():S52-4. PubMed ID: 11794478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired color vision defects in retrobulbar neuritis.
    Griffin JF; Wray SH
    Am J Ophthalmol; 1978 Aug; 86(2):193-201. PubMed ID: 686121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy.
    Gregori B; Papazachariadis O; Farruggia A; Accornero N
    J Neurol Sci; 2011 Jan; 300(1-2):130-4. PubMed ID: 20875905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
    Gundogan FC; Tas A; Altun S; Oz O; Erdem U; Sobaci G
    Indian J Ophthalmol; 2013 Mar; 61(3):100-3. PubMed ID: 23514643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast sensitivity and other vision tests in the optic neuritis treatment trial.
    Trobe JD; Beck RW; Moke PS; Cleary PA
    Am J Ophthalmol; 1996 May; 121(5):547-53. PubMed ID: 8610798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
    Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
    Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual evoked potential and pupillary signs. A comparison in optic nerve disease.
    Cox TA; Thompson HS; Hayreh SS; Snyder JE
    Arch Ophthalmol; 1982 Oct; 100(10):1603-7. PubMed ID: 7138329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'flicker test' according to Aulhorn in the diagnosis of acute optic neuritis.
    Christ T; Pillunat LE; Stodtmeister R
    Ophthalmologica; 1986; 192(4):220-7. PubMed ID: 3748555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of visual evoked potentials in the differential diagnosis of functional visual loss and optic neuritis in children.
    Suppiej A; Gaspa G; Cappellari A; Toldo I; Battistella PA
    J Child Neurol; 2011 Jan; 26(1):58-64. PubMed ID: 20587737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visual evoked potential and relative afferent pupillary defect in patients with unilateral optic neuritis].
    Nagashima Y; Kato M; Watanabe I
    Nippon Ganka Gakkai Zasshi; 1991 Oct; 95(10):1004-8. PubMed ID: 1746365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical optic neuropathy in multiple sclerosis. A neuro-ophthalmological investigation by means of visually evoked response, Farnworth-Munsell 100 Hue test and Ishihara test and their diagnostic value.
    Engell T; Trojaborg W; Raun NE
    Acta Ophthalmol (Copenh); 1987 Dec; 65(6):735-40. PubMed ID: 3434241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative afferent pupillary defects in optic neuritis.
    Cox TA; Thompson HS; Corbett JJ
    Am J Ophthalmol; 1981 Nov; 92(5):685-90. PubMed ID: 7304695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Farnsworth-Munsell 100 hue test and optic neuritis.
    Hoyt CS
    Br J Ophthalmol; 1993 Feb; 77(2):65. PubMed ID: 8435419
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Uhthoff's symptom in disseminated sclerosis by the Farnsworth-Munsell 100-hue test and the octopus perimetry.
    Zrenner E
    Dev Ophthalmol; 1984; 9():182-7. PubMed ID: 6335437
    [No Abstract]   [Full Text] [Related]  

  • 18. The differential diagnosis of retinal disease from optic nerve disease.
    Sherman J; Bass SJ; Richardson V
    J Am Optom Assoc; 1981 Dec; 52(12):933-9. PubMed ID: 7328258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.
    Yuksel B; Dogan B; Koctekin B; Atis N; Erdal A; Kurtulus F; Erol MK; Gomceli YB
    J Clin Neurosci; 2019 Mar; 61():48-53. PubMed ID: 30455132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.